There is limited data available specific to ESRD because psychiatric clical trials usually exclude patients with ESRD. Unfortunately, data regarding the effectiveness and safety of psychotherapeutic agents in ESRD patients is also limited. A number of medications, such as tricyclic antidepressants, have resulted in adverse effects that need to be avoided. All psychotherapeutic medications should be started at low doses and increased carefully while being closely monitored. It is critically important to collaborate withe patient’s nephrologist to tailor the approp Post navigation
